Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy

Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy

Abstract Purpose We aimed to determine the prognostic value of α-hydroxybutyrate dehydrogenase (α-HBDH) in upper tract urothelial carcinoma (UTUC) patients after radical nephroureterectomy (RNU). Materials and methods We retrospectively enrolled the data of 544 UTUC patients at West China Hospital f...

Full description

Bibliographic Details
Main Authors: Jianjun Ye, Lei Zheng, Zeyu Chen, Qihao Wang, Xinyang Liao, Xingyuan Wang, Qiang Wei, Yige Bao
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Urology
Subjects:
α-hydroxybutyrate dehydrogenase
Upper tract urothelial carcinoma
Radical nephroureterectomy
Biomarker
Outcome
Online Access:https://doi.org/10.1186/s12894-024-01439-2

Internet

https://doi.org/10.1186/s12894-024-01439-2

Similar Items